Clinical trial
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3
NCT00000328 · University of Colorado, Denver, Other · Withdrawn
Key facts
| NCT number | NCT00000328 |
|---|---|
| Title | Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3 |
| Official title | Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III |
| Lead sponsor | University of Colorado, Denver, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Heroin Dependence, Opioid-Related Disorders |
| Intervention type | Drug |
| Interventions | Opioid-Related Disorders |
| Enrollment | 0 |
| Start date | Jul 1, 1997 |
| Primary completion | Aug 1, 1997 |
| Completion | Aug 1, 1997 |
| First posted | Sep 21, 1999 |
| Last update posted | May 4, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: